Recruiting Vasculitis Studies in Pittsburgh
Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)
This study aims to investigate the efficacy and safety of depemokimab compared with mepolizumab in adults with relapsing or refractory EGPA receiving SoC therapy....
Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.
The main objective of this study is to explore the efficacy of avacopan in participants affected by AAV....
About Vasculitis Clinical Trials in Pittsburgh
Vasculitis refers to a group of disorders that involve inflammation of blood vessels, which can restrict blood flow and damage organs. Types include ANCA-associated vasculitis, giant cell arteritis, and Takayasu arteritis. Treatment typically involves corticosteroids and immunosuppressive medications.
There are currently 2 vasculitis clinical trials recruiting participants in Pittsburgh, PENNSYLVANIA. These studies are seeking a combined 180 participants. Research is being sponsored by GlaxoSmithKline, Amgen. Clinical trial participation is free and participants receive study-related medical care at no cost.
Vasculitis Clinical Trials in Pittsburgh — FAQ
Are there vasculitis clinical trials in Pittsburgh?
Yes, there are 2 vasculitis clinical trials currently recruiting in Pittsburgh, PENNSYLVANIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Pittsburgh?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Pittsburgh research site will contact you about next steps.
Are clinical trials in Pittsburgh free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Pittsburgh studies also compensate for your time and travel.
What vasculitis treatments are being tested?
The 2 active trials in Pittsburgh are testing new therapies including novel drugs, biologics, and treatment approaches for vasculitis.
Data updated March 2, 2026 from ClinicalTrials.gov